SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12243818
Source:
http://linkedlifedata.com/resource/pubmed/id/12243818
Search
Subject
(
52
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0178602
,
umls-concept:C0376358
,
umls-concept:C0439234
,
umls-concept:C0871261
,
umls-concept:C1522577
,
umls-concept:C1704632
,
umls-concept:C1706817
,
umls-concept:C2911692
pubmed:issue
2
pubmed:dateCreated
2002-9-23
pubmed:abstractText
This communication reports the long-term results of the original group of prostate cancer patients who participated in the first prospective Fox Chase Cancer Center radiation dose escalation study for which 8-12 years of follow-up is now available.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0360-3016
pubmed:author
pubmed-author:EpsteinBarryB
,
pubmed-author:HanksGerald EGE
,
pubmed-author:HanlonAlexandra LAL
,
pubmed-author:HorwitzEric MEM
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
427-35
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:12243818-Actuarial Analysis
,
pubmed-meshheading:12243818-Aged
,
pubmed-meshheading:12243818-Aged, 80 and over
,
pubmed-meshheading:12243818-Analysis of Variance
,
pubmed-meshheading:12243818-Dose-Response Relationship, Radiation
,
pubmed-meshheading:12243818-Follow-Up Studies
,
pubmed-meshheading:12243818-Gastrointestinal Hemorrhage
,
pubmed-meshheading:12243818-Humans
,
pubmed-meshheading:12243818-Male
,
pubmed-meshheading:12243818-Middle Aged
,
pubmed-meshheading:12243818-Neoplasm Staging
,
pubmed-meshheading:12243818-Proportional Hazards Models
,
pubmed-meshheading:12243818-Prospective Studies
,
pubmed-meshheading:12243818-Prostate-Specific Antigen
,
pubmed-meshheading:12243818-Prostatic Neoplasms
,
pubmed-meshheading:12243818-Radiotherapy, Conformal
,
pubmed-meshheading:12243818-Rectum
,
pubmed-meshheading:12243818-Treatment Outcome
pubmed:year
2002
pubmed:articleTitle
Dose response in prostate cancer with 8-12 years' follow-up.
pubmed:affiliation
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
pubmed:publicationType
Journal Article